000 03746nlm1a2200469 4500
001 656565
005 20231030041433.0
035 _a(RuTPU)RU\TPU\network\23006
035 _aRU\TPU\network\21762
090 _a656565
100 _a20171120a2015 k y0engy50 ba
101 0 _aeng
102 _aUA
135 _adrcn ---uucaa
181 0 _ai
182 0 _ab
200 1 _aSmoking-related DNA adducts as potential diagnostic markers of lung cancer: new perspectives
_fE. S. Grigorjeva [et al.]
203 _aText
_celectronic
300 _aTitle screen
320 _a[References: p. 11-12 (74 tit.)]
330 _aIn recent years, the new direction such as identification of informative circulating markers reflecting molecular genetic changes in the DNA of tumor cells was actively developed. Smoking-related DNA adducts are very promising research area, since they indicate high pathogenetic importance in the lung carcinogenesis and can be identified in biological samples with high accuracy and reliability using highly sensitive mass spectrometry methods (TOF/TOF, TOF/MS, MS/MS). The appearance of DNA adducts in blood or tissues is the result of the interaction of carcinogenic factors, such as tobacco constituents, and the body reaction which is determined by individual characteristics of metabolic and repair systems. So, DNA adducts may be considered as a cumulative mirror of heterogeneous response of different individuals to smoking carcinogens, which finally could determine the risk for lung cancer. This review is devoted to analysis of the role of DNA adducts in lung carcinogenesis in order to demonstrate their usefulness as cancer associated markers. Currently, there are some serious limitations impeding the widespread use of DNA adducts as cancer biomarkers, due to failure of standardization of mass spectrometry analysis in order to correctly measure the adduct level in each individual. However, it is known that all DNA adducts are immunogenic, their accumulation over some threshold concentration leads to the appearance of long-living autoantibodies. Thus, detection of an informative pattern of autoantibodies against DNA adducts using innovative multiplex ELISA immunoassay may be a promising approach to find lung cancer at an early stage in high-risk groups (smokers, manufacturing workers, urban dwellers).
461 _tExperimental Oncology
463 _tVol. 37, № 1
_v[P. 5-12]
_d2015
610 1 _aэлектронный ресурс
610 1 _aтруды учёных ТПУ
610 1 _alung cancer
610 1 _aDNA adducts
610 1 _asmoking
610 1 _aДНК
610 1 _aкурение
610 1 _aрак легких
701 1 _aGrigorjeva
_bE. S.
_gElena Sergeevna
701 1 _aKokova
_bD. A.
_gDarjya Alekseevna
701 1 _aGrachev
_bA. N.
701 1 _aCherdyntsev
_bE. S.
_cspecialist in the field of informatics and computer technology
_cAssociate Professor of Tomsk Polytechnic University, candidate of technical sciences
_f1953-
_gEvgeny Sergeevich
_2stltpush
_3(RuTPU)RU\TPU\pers\36884
701 1 _aBuldakov
_bM. A.
_gMikhail Aleksandrovich
701 1 _aKzhyshkowska
_bJ. G.
701 1 _aCherdyntseva
_bN. V.
_gNadezhda Viktorovna
712 0 2 _aНациональный исследовательский Томский политехнический университет (ТПУ)
_bИнститут кибернетики (ИК)
_bКафедра оптимизации систем управления (ОСУ)
_h127
_2stltpush
_3(RuTPU)RU\TPU\col\18702
801 2 _aRU
_b63413507
_c20171120
_gRCR
856 4 _uhttp://exp-oncology.com.ua/article/7445/smoking-related-dna-adducts-as-potential-diagnostic-markers-of-lung-cancer-new-perspectives
942 _cCF